CareRay Digital Medical Technology Co Ltd
CareRay Digital Medical Technology Co., Ltd. engages in research and development, production, and sales of digital X-ray flat panel detectors in China. The company offers Gen3 panels; radiography products, including wireless, tethered, and specialized panels, as well as accessories; mammography, fluoroscopy, dental, and industrial NDT products; and custom panels. It also provides solutions for re… Read more
CareRay Digital Medical Technology Co Ltd (688607) - Net Assets
Latest net assets as of September 2025: CN¥858.27 Million CNY
Based on the latest financial reports, CareRay Digital Medical Technology Co Ltd (688607) has net assets worth CN¥858.27 Million CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥988.48 Million) and total liabilities (CN¥130.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥858.27 Million |
| % of Total Assets | 86.83% |
| Annual Growth Rate | 23.75% |
| 5-Year Change | 133.84% |
| 10-Year Change | N/A |
| Growth Volatility | 44.98 |
CareRay Digital Medical Technology Co Ltd - Net Assets Trend (2017–2024)
This chart illustrates how CareRay Digital Medical Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CareRay Digital Medical Technology Co Ltd (2017–2024)
The table below shows the annual net assets of CareRay Digital Medical Technology Co Ltd from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥862.51 Million | +0.52% |
| 2023-12-31 | CN¥858.07 Million | +1.65% |
| 2022-12-31 | CN¥844.16 Million | -3.07% |
| 2021-12-31 | CN¥870.90 Million | +136.12% |
| 2020-12-31 | CN¥368.84 Million | +25.62% |
| 2019-12-31 | CN¥293.61 Million | +19.74% |
| 2018-12-31 | CN¥245.21 Million | +26.34% |
| 2017-12-31 | CN¥194.09 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CareRay Digital Medical Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 20507048101.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥201.53 Million | 23.37% |
| Common Stock | CN¥88.13 Million | 10.22% |
| Other Comprehensive Income | CN¥36.64 Million | 4.25% |
| Other Components | CN¥536.24 Million | 62.17% |
| Total Equity | CN¥862.54 Million | 100.00% |
CareRay Digital Medical Technology Co Ltd Competitors by Market Cap
The table below lists competitors of CareRay Digital Medical Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shanghai Baosteel Packaging
SHG:601968
|
$433.98 Million |
|
Bank Sinarmas Tbk
JK:BSIM
|
$434.00 Million |
|
Precigen Inc
NASDAQ:PGEN
|
$434.08 Million |
|
CHTC Helon Co Ltd
SHE:000677
|
$434.09 Million |
|
Petroreconcavo S.A
SA:RECV3
|
$433.71 Million |
|
Black Peony Group Co Ltd
SHG:600510
|
$433.47 Million |
|
Jiangsu Changhai Compos Material
SHE:300196
|
$433.44 Million |
|
IFCI Limited
NSE:IFCI
|
$433.35 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CareRay Digital Medical Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 858,123,119 to 862,540,338, a change of 4,417,219 (0.5%).
- Net income of 17,652,732 contributed positively to equity growth.
- Dividend payments of 5,018,959 reduced retained earnings.
- Share repurchases of 10,001,996 reduced equity.
- Other comprehensive income increased equity by 36,640,082.
- Other factors decreased equity by 34,854,640.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥17.65 Million | +2.05% |
| Dividends Paid | CN¥5.02 Million | -0.58% |
| Share Repurchases | CN¥10.00 Million | -1.16% |
| Other Comprehensive Income | CN¥36.64 Million | +4.25% |
| Other Changes | CN¥-34.85 Million | -4.04% |
| Total Change | CN¥- | 0.51% |
Book Value vs Market Value Analysis
This analysis compares CareRay Digital Medical Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.58x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 16.84x to 5.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥3.24 | CN¥54.50 | x |
| 2018-12-31 | CN¥3.73 | CN¥54.50 | x |
| 2019-12-31 | CN¥4.67 | CN¥54.50 | x |
| 2020-12-31 | CN¥4.18 | CN¥54.50 | x |
| 2021-12-31 | CN¥9.88 | CN¥54.50 | x |
| 2022-12-31 | CN¥9.58 | CN¥54.50 | x |
| 2023-12-31 | CN¥9.47 | CN¥54.50 | x |
| 2024-12-31 | CN¥9.77 | CN¥54.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CareRay Digital Medical Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.92%
- • Asset Turnover: 0.31x
- • Equity Multiplier: 1.12x
- Recent ROE (2.05%) is below the historical average (10.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 11.12% | 10.90% | 0.77x | 1.32x | CN¥2.18 Million |
| 2018 | 20.10% | 23.17% | 0.72x | 1.21x | CN¥24.76 Million |
| 2019 | 16.41% | 20.54% | 0.61x | 1.30x | CN¥18.83 Million |
| 2020 | 20.38% | 22.15% | 0.79x | 1.17x | CN¥38.26 Million |
| 2021 | 9.77% | 24.88% | 0.36x | 1.08x | CN¥-2.00 Million |
| 2022 | -0.67% | -2.77% | 0.23x | 1.07x | CN¥-90.09 Million |
| 2023 | 1.80% | 5.63% | 0.29x | 1.10x | CN¥-70.40 Million |
| 2024 | 2.05% | 5.92% | 0.31x | 1.12x | CN¥-68.60 Million |
Industry Comparison
This section compares CareRay Digital Medical Technology Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CareRay Digital Medical Technology Co Ltd (688607) | CN¥858.27 Million | 11.12% | 0.15x | $433.85 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |